Storage burden was attenuated in the thalamus and cerebellum for the majority of ICV treated sheep, and significantly reduced in the thalamus of MD treated sheep and the cerebellum and thalamus of HD treated sheep when compared with untreated CLN5−/− sheep (Figure 7; Supplementary Figure S6). Here, CLN5 is linked to Huntington disease.